About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tg(Nes-cre/ERT2)KEisc
transgene insertion K, Amelia Eisch
MGI:3767432
Summary 2 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
cn1
Tet1tm1Gxu/Tet1tm1.1Gxu
Tg(Nes-cre/ERT2)KEisc/0
involves: 129 * C57BL/6J MGI:5523877
cn2
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Resttm1.1Jhsi/Resttm1.1Jhsi
Tg(Nes-cre/ERT2)KEisc/0
involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * SJL MGI:5141116


Genotype
MGI:5523877
cn1
Allelic
Composition
Tet1tm1Gxu/Tet1tm1.1Gxu
Tg(Nes-cre/ERT2)KEisc/0
Genetic
Background
involves: 129 * C57BL/6J
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tet1tm1.1Gxu mutation (0 available); any Tet1 mutation (142 available)
Tet1tm1Gxu mutation (0 available); any Tet1 mutation (142 available)
Tg(Nes-cre/ERT2)KEisc mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• mice treated with tamoxifen at 2 months of age exhibit impaired adult neurogenesis compared with control mice
• mice treated with tamoxifen at 2 months of age exhibit decreased proliferation of intermediate progenitor cells in the dentate gyrus compared with control mice

cellular
• mice treated with tamoxifen at 2 months of age exhibit impaired adult neurogenesis compared with control mice
• mice treated with tamoxifen at 2 months of age exhibit decreased proliferation of intermediate progenitor cells in the dentate gyrus compared with control mice




Genotype
MGI:5141116
cn2
Allelic
Composition
Gt(ROSA)26Sortm1(EYFP)Cos/Gt(ROSA)26Sor+
Resttm1.1Jhsi/Resttm1.1Jhsi
Tg(Nes-cre/ERT2)KEisc/0
Genetic
Background
involves: 129S6/SvEvTac * 129X1/SvJ * C57BL/6 * SJL
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(EYFP)Cos mutation (11 available); any Gt(ROSA)26Sor mutation (944 available)
Resttm1.1Jhsi mutation (1 available); any Rest mutation (95 available)
Tg(Nes-cre/ERT2)KEisc mutation (1 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
• 20 days after tamoxifen treatment, mice exhibit a transient increase in hippocampal neurogenesis compared with control mice
• tamoxifen-treatment increased hippocampal neurogenesis in vitro and in vivo compared with controls
• tamoxifen-treated mice exhibit premature exit of quiescence compared with control mice
• tamoxifen-treated mice exhibit loss of neurogenic capacity of adult neurospheres and decreased neurogenesis over time compared with control mice
• neurospheres treated from tamoxifen-treated mice exhibit reduced self-renewal capacity compared with wild-type cells
• however, hippocampal neurogenesis is normal 10 and 30 days after tamoxifen treatment
• in tamoxifen-treated mice
• tamoxifen-treated mice exhibit decreased adult-generated immature and mature granule neurons compared with control mice

cellular
• 20 days after tamoxifen treatment, mice exhibit a transient increase in hippocampal neurogenesis compared with control mice
• tamoxifen-treatment increased hippocampal neurogenesis in vitro and in vivo compared with controls
• tamoxifen-treated mice exhibit premature exit of quiescence compared with control mice
• tamoxifen-treated mice exhibit loss of neurogenic capacity of adult neurospheres and decreased neurogenesis over time compared with control mice
• neurospheres treated from tamoxifen-treated mice exhibit reduced self-renewal capacity compared with wild-type cells
• however, hippocampal neurogenesis is normal 10 and 30 days after tamoxifen treatment
• in tamoxifen-treated mice





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
05/07/2024
MGI 6.23
The Jackson Laboratory